Skip to main content
en-GBii-CN

Newsroom

Advanced Oncotherapy PLC demonstrates the potential superiority of LIGHT in treating breast cancer patients

2022年11月30日

Dr Jonathan Farr DSc, Chief Clinical Officer of Advanced Oncotherapy plc, presents the results of a recent study undertaken with partners the Cleveland Clinic, which demonstrates the potential advantages of treating breast cancer with the LIGHT system, when compared to conventional cyclotrons. The study demonstrates that LIGHT proton minibeams could result in up to 99% reduction in radiation dose to critical organs, the heart and lungs, compared with cyclotron-generated protons.

230 MeV Maximum Energy Achieved

2022年10月11日

On 26th September 2022 Advanced Oncotherapy reached a critical milestone in our journey in bringing a new linear accelerator proton treatment system to the market - the acceleration of the proton beam up to maximum system energy of 230 MeV.

The advanced LIGHT conformal scanned FLASH capability is favourably compared to cyclotron passive FLASH

2022年06月15日

Dr. Jonathan Farr, Chief Clinical Officer of Advanced Oncotherapy recently presented to the global medical physics and biomedical engineering community at IUPESM World Congress in Singapore. His presentation entitled “Ultra-High Dose Rate Production and Delivery Systems Intended for Flash”.

Advanced Oncotherapy PLC on its proton beam therapy system

2022年05月13日

Dr. Jonathan Farr, Chief Clinical Officer of Advanced Oncotherapy interviewed with ProactiveInvestors to talk about the company's LIGHT, proton beam therapy system.

Top 10 Impactful Healthcare Leaders to Watch in 2022: Interview with Beyond Exclamation Magazine

2022年05月10日

Nicolas Serandour, CEO of Advanced Oncotherapy is featured in the top 10 impactful healthcare leaders to watch in 2022. See his story on page 20 and his vision to democratise proton therapy.

NICOLAS SERANDOUR'S INTERVIEW WITH Proactive investors

2022年03月31日

Nicolas Serandour, CEO of Advanced Oncotherapy, interviewed with Proactive investors to discuss about democratising Proton Beam Therapy and provides an update on the development of the LIGHT system.

Study shows potential of Advanced Oncotherapy’s LIGHT proton therapy for resistant cancers

2021年03月19日

Advanced Oncotherapy plc reported new findings demonstrating the potential ability and superiority of its next-generation proton therapy system, LIGHT, to treat resistant cancers. The findings build on research at the Mayo Clinic that highlighted the benefits of combining proton therapy (PT) with targeted small molecule damage repair inhibitors.

UK Investormagazine Podcast

2021年02月12日

The UK Investor Magazine Podcast was joined by Nicolas Serandour, CEO of Advanced Oncotherapy, to discuss the latest progress in democratising Proton Beam Therapy.

Investigation on the PBS FLASH Beam Delivery Technique Using a Proton Linac by Dr. Jonathan Farr and Dr. Anna Kolano

2020年10月25日

This study aims to investigate the use of proton Pencil Beam Scanning (PBS) for uniform FLASH irradiations in clinical and (radio)biology settings using a pulsed proton therapy Linac and to report on PBS FLASH beam delivery possibilities and limitations.

Proton LINAC Transverse Beam Scanning Performance Implications for Therapeutic Quality Improvement by Dr. Jonathan Farr and Dr. Anna Kolano

2020年10月25日

The purpose of the study is to determine which clinical indications benefit most and by how much from minimizing and holding a proton scanning spot size constant over the range 150-230 MeV in comparison to existing systems and techniques.

Investor Day Update

2020年10月19日

Advanced Oncotherapy held its Investor Day presentation on 19 October 2020. A recording of the presentation and of the full Q&A is available on the Investor Meet Company platform.

Advanced Oncotherapy progresses towards ‘democratising proton therapy’ by UK Investor Magazine

2020年10月02日

Advanced Oncotherapy (AIM:AVO), developer of proton therapy systems for cancer treatment, recently announced several areas of progress which will help realise its goal of ‘democratising proton therapy’.

BENEFITS OF CLOUD HOSTING FOR PBT

2020年09月23日

Euan S. Thomson, PhD., Global President Ophthalmic Devices and Head of Digital Business Unit for Carl Zeiss Meditec, and Medical Advisor to Advanced Oncotherapy plc, shares his views on the future of data sharing for proton therapy and for Advanced Oncotherapy plc in particular. Treatment planning for proton therapy is complex and requires a number of steps to achieve the desired dose distributions. Without a national or international strategy to coordinate unified treatment protocols, patients treated with protons have been managed with several delivery modalities, treatment paradigms and fractionation schemes. A key area for optimising the treatment planning process is therefore in gaining experience by encouraging all centres to share treatment plans with each other, retrospectively and in real time. To facilitate this process, Advanced Oncotherapy is working on treatment planning software to be hosted on the cloud.

Immunotherapy and PBT

2020年07月24日

The combination of proton therapy with immunotherapy is considered promising and has gained substantial interest over the last 2 years. According to Prof Justin Stebbing, an internationally acclaimed expert in immunotherapies for cancer, “the synergies between immunotherapy and radiotherapy can potentially allow for better treatment of cancers, improving both quality and quantity of life.” A recent paper published in the British Journal of Radiology shows that proton therapy might be better adapted to for combination with immunotherapy because it causes less damage to the immune cells and induces a stronger immune response due to a different cell death mechanism.

Ahead of the ASTRO conference in October

2020年06月25日

FLASH continues to prove its unique advantages in healthy tissue sparing with tumour control even in radioresistant cases. The LIGHT system is uniquely suited to application of FLASH at all depths. Currently we are investigating the delivery FLASH dose rates for a wide range of spot sizes. Follow us at upcoming ASTRO for more details!

New paths to proton therapy

2020年04月30日

On page 83-85 of Healthcare in London magazine, CEO of Advanced Oncotherapy plc, Nicolas Serandour provides an update on the development of the LIGHT system.

Nicolas Serandour's interview with London Suisse Luxe Magazine

2020年03月09日

Nicolas Serandour is CEO of Advanced Oncotherapy plc, a company not only at the forefront of developing a new proton beam therapy system, but also at the heart of a move to make this treatment available to people who would never normally have access to it.

Prognosis magazine interviewed Michael Sinclair, executive chairman of Advanced Oncotherapy

2020年02月27日

On bringing proton beam therapy, a revolutionary new cancer treatment, to Harley Street

A Win for Protons in Pediatric Brain Tumors

2019年12月23日

New data supporting the benefit of proton therapy is continuously emerging. See what Medpage says about proton therapy for paediatric brain tumours.

Advanced Oncotherapy readies first linear proton beam accelerator system for debut

2019年12月09日

Advanced Oncotherapy plc is starting verification and validation of the world’s first linear proton beam accelerator system, which is assembled and ready for testing at the Daresbury particle physics laboratory in Cheshire, U.K.

Advanced Oncotherapy PLC: Q&A with The Howard de Walden Estate

2019年09月23日

Building work at 141-143 Harley Street, the site of Advanced Oncotherapy’s first proposed commercial installation of LIGHT, has been recently completed. The Company just announced handover ahead of the fit-out process. Below is a Q&A with Simon Baynham, the property director at The Howard de Walden Estate, the landlord and developer of the Harley Street Medical Area.

PBT will become as common as MRI scanning

2019年08月09日

Because our LIGHT system has been designed to significantly reduce the treatment cost of patient and it can be installed in small to mid-size health care centres throughout the country, every patient ought to benefit from a proton therapy centre in their vicinity which is expected to drive patients’ demand for this treatment.

Advanced Oncotherapy: Democratising proton beam therapy

2019年07月08日

Check out the interview granted by Moataz Karmalawy, President of US division and Chief Commercial Officer of Advanced Oncotherapy.

FT: UK biotechs seek to speed up cancer detection

2019年06月07日

Nicolas Serandour speaks to Sarah Neville about how LIGHT's streamlined design is going to help to bridge the gap between resources and demand, and “democratise” proton beam therapy, a treatment that can make a difference.

The Times: Proton beams ‘better at treating brain tumours’.

2019年06月02日

The news could scarcely have been better for Harry Muldowney, a 10-year-old Herefordshire schoolboy with a brain tumour. Last month he became one of the first NHS patients to begin a potentially life-saving course of proton beam therapy, a pioneering cancer treatment.

Accelerating Innovation through International Collaboration

2019年03月22日

Prof Steve Myers, Executive Chair ADAM and former Director of Accelerators at CERN, was in Liverpool to talk about ‘Accelerating Innovation through International Collaboration’.

Girl, 9, survives inoperable cancer after proton beam therapy

2019年03月20日

The front page of the Times features the story of how Caroline, a 9-year-old British girl diagnosed with a rare inoperable cancer known as a rhabdomyosarcoma, has made a full recovery thanks to proton beam therapy. Also available on StoryTrender

A Meyrin, on dessine la firme de demain

2019年02月09日

[Article in French] Listed on the London Stock Exchange, Advanced Oncotherapy believes it has discovered a real vein: the development of a new system focused on proton therapy. This promising technology fights cancer.

AVO's linear proton accelerator LIGHT showcased on Japanese TV

2018年11月23日

In October 2018, NHK World TV visited the ADAM bunker facility in Geneva and interviewed ADAM Chairman, Former CERN Director of Accelerators and Technology, Prof. Stephen Myers OBE.

Effect of radiation exposure in brain tumours on hormone deficiencies

2018年08月21日

This article in the Journal of Clinical Oncology provides strong support for the benefits of advanced radiation technologies such as proton therapy for the treatment of brain tumours, especially in younger patients.

AVO’s CEO Nicolas Serandour: Proton therapy is going to become a reality for every cancer patient

2018年08月08日

AVO’s CEO Nicolas Serandour explains how the LIGHT system will significantly decrease the costs of proton therapy and allow to treat more kinds of cancer. “Proton therapy is going to become a reality for every cancer patient” - says Serandour

Proton therapy goes slimline-Manufacturers are reducing the size of proton-therapy systems to better compete with traditional radiotherapy

2018年08月01日

Physics World reports - Physics World reports on advances in proton therapy technology. Our LIGHT system is also discussed.

LIGHT was discussed at the first International Symposium on the Next Generation of Hadron Therapy in Tsukuba, Japan

2018年07月09日

CERN Courier - "The first model of LIGHT, a linac-based hadron-therapy system that operates at [200 Hz] with an energy sweep, and which is going to be installed at Harley Street, London" was discussed at the first International Symposium on the Next Generation of Hadron Therapy in Tsukuba, Japan. See the article in the last edition of the CERN Courier.

Beams of Life | Mega | in conversation with Stephen Myers

2018年05月23日

Proton therapy is a new way of beating cancer, with fewer side effects than conventional radiation treatments, explains Stephen Myers a pioneering nuclear medicine scientist.

All About Proton Therapy

2018年02月01日

Carolyn Vachani (University of Pennsylvania) - OncoLink.com - This article compares various radiation oncology techniques.

Therapeutic particles

2018年01月01日

Virginia Greco (CERN) - CERN Courier - The history of proton therapy.

Huge leap in prostate cancer testing

2018年01月01日

BBC news

Advanced Oncotherapy gets boost from stalwart investor

2017年12月10日

by Financial Times, Kate Burgess

AVO is fortunate to have investor stalwarts at its back

2017年12月10日

Financial Times - Investors trust, that the LIGHT system is the future of proton therapy.

Three ways to make proton therapy affordable

2017年09月01日

Thomas Bortfeld & Jay Loeffler (Mass. Gen. Hospital, Harvard Medical School) - Nature - Shrinking the accelerators and treatment room machines as well as model-based reimbursement decisions and pan-national referrals should decrease the cost of proton therapy and the scope of cancers treated.

Impact of spot charge inaccuracies in IMPT treatments

2017年08月01日

A.C. Kraan, N. Depauw, B. Clasie, M. Giunta, T. Madden, Hanne M. Kooy - Medical Physics Volume 44, Issue 8 - Pencil-beam scanning in proton therapy is even more accurate than what would be medically necessary.

Fundamental Research as a Driver for Disruption, Presentation by Prof Steve Myers

2017年06月23日

At its annual corporate event organised in Sardinia in 2017, Goetzpartners brought together personalities from all backgrounds. Prof Steve Myers, Executive Chairman of ADAM and Director of Advanced Oncotherapy plc, was invited to present the LIGHT Technology.

Director Talks meets Hans Van Celsing

2017年04月10日

Following his appointment at Senior Independent Non-Executive Director, Hans von Celsing talks to DirectorsTalk about his past experience, the present and his thoughts on the future of the company.

LIGHT: A Linear Accelerator For Proton Therapy

2016年10月01日

A. Degiovanni, P. Stabile, D. Ungaro (A.D.A.M. SA) - NAPAC2016, Chicago, IL, USA - A detailed presentation of our proton therapy system.

A(relatively) risky business: the link between prostatic radiotherapy and second malignancies

2016年03月01日

The BMJ - Radiotherapy increases the probability of secondary malignancies in prostate cancer patients. Another argument for a more wide-spread use of proton therapy?

Ashya King proton beam cancer therapy 'causes fewer side effects'

2016年01月01日

BBC News - Patient story about, how proton therapy is the better option in children's cancer.

Scientists put final pieces into place for seeing cancer with protons'

2016年01月01日

Proton beam are not only useful in radiation therapy, but also as an imagining technique.

Ashya King goes back to school full time'

2016年01月01日

The Guardian - Thanks to proton therapy treatment the little Ashya King recovered very fast.

Proton radiation therapy shows ongoing advancements throughout past quarter century'

2015年07月01日

TMC news - A timeline of proton beam therapy development.

The Physics of Proton Therapy

2015年03月01日

Wayne Newhauser & Rui Zhang - Physics in Medicine & Biology - Proton beam therapy explained by physicists.

Advanced Oncotherapy PLC demonstrates the potential superiority of LIGHT in treating breast cancer patients

2022年11月30日

Dr Jonathan Farr DSc, Chief Clinical Officer of Advanced Oncotherapy plc, presents the results of a recent study undertaken with partners the Cleveland Clinic, which demonstrates the potential advantages of treating breast cancer with the LIGHT system, when compared to conventional cyclotrons. The study demonstrates that LIGHT proton minibeams could result in up to 99% reduction in radiation dose to critical organs, the heart and lungs, compared with cyclotron-generated protons.

230 MeV Maximum Energy Achieved

2022年10月11日

On 26th September 2022 Advanced Oncotherapy reached a critical milestone in our journey in bringing a new linear accelerator proton treatment system to the market - the acceleration of the proton beam up to maximum system energy of 230 MeV.

The advanced LIGHT conformal scanned FLASH capability is favourably compared to cyclotron passive FLASH

2022年06月15日

Dr. Jonathan Farr, Chief Clinical Officer of Advanced Oncotherapy recently presented to the global medical physics and biomedical engineering community at IUPESM World Congress in Singapore. His presentation entitled “Ultra-High Dose Rate Production and Delivery Systems Intended for Flash”.

Advanced Oncotherapy PLC on its proton beam therapy system

2022年05月13日

Dr. Jonathan Farr, Chief Clinical Officer of Advanced Oncotherapy interviewed with ProactiveInvestors to talk about the company's LIGHT, proton beam therapy system.

Top 10 Impactful Healthcare Leaders to Watch in 2022: Interview with Beyond Exclamation Magazine

2022年05月10日

Nicolas Serandour, CEO of Advanced Oncotherapy is featured in the top 10 impactful healthcare leaders to watch in 2022. See his story on page 20 and his vision to democratise proton therapy.

NICOLAS SERANDOUR'S INTERVIEW WITH Proactive investors

2022年03月31日

Nicolas Serandour, CEO of Advanced Oncotherapy, interviewed with Proactive investors to discuss about democratising Proton Beam Therapy and provides an update on the development of the LIGHT system.

Study shows potential of Advanced Oncotherapy’s LIGHT proton therapy for resistant cancers

2021年03月19日

Advanced Oncotherapy plc reported new findings demonstrating the potential ability and superiority of its next-generation proton therapy system, LIGHT, to treat resistant cancers. The findings build on research at the Mayo Clinic that highlighted the benefits of combining proton therapy (PT) with targeted small molecule damage repair inhibitors.

UK Investormagazine Podcast

2021年02月12日

The UK Investor Magazine Podcast was joined by Nicolas Serandour, CEO of Advanced Oncotherapy, to discuss the latest progress in democratising Proton Beam Therapy.

Investigation on the PBS FLASH Beam Delivery Technique Using a Proton Linac by Dr. Jonathan Farr and Dr. Anna Kolano

2020年10月25日

This study aims to investigate the use of proton Pencil Beam Scanning (PBS) for uniform FLASH irradiations in clinical and (radio)biology settings using a pulsed proton therapy Linac and to report on PBS FLASH beam delivery possibilities and limitations.

Proton LINAC Transverse Beam Scanning Performance Implications for Therapeutic Quality Improvement by Dr. Jonathan Farr and Dr. Anna Kolano

2020年10月25日

The purpose of the study is to determine which clinical indications benefit most and by how much from minimizing and holding a proton scanning spot size constant over the range 150-230 MeV in comparison to existing systems and techniques.

Investor Day Update

2020年10月19日

Advanced Oncotherapy held its Investor Day presentation on 19 October 2020. A recording of the presentation and of the full Q&A is available on the Investor Meet Company platform.

Advanced Oncotherapy progresses towards ‘democratising proton therapy’ by UK Investor Magazine

2020年10月02日

Advanced Oncotherapy (AIM:AVO), developer of proton therapy systems for cancer treatment, recently announced several areas of progress which will help realise its goal of ‘democratising proton therapy’.

BENEFITS OF CLOUD HOSTING FOR PBT

2020年09月23日

Euan S. Thomson, PhD., Global President Ophthalmic Devices and Head of Digital Business Unit for Carl Zeiss Meditec, and Medical Advisor to Advanced Oncotherapy plc, shares his views on the future of data sharing for proton therapy and for Advanced Oncotherapy plc in particular. Treatment planning for proton therapy is complex and requires a number of steps to achieve the desired dose distributions. Without a national or international strategy to coordinate unified treatment protocols, patients treated with protons have been managed with several delivery modalities, treatment paradigms and fractionation schemes. A key area for optimising the treatment planning process is therefore in gaining experience by encouraging all centres to share treatment plans with each other, retrospectively and in real time. To facilitate this process, Advanced Oncotherapy is working on treatment planning software to be hosted on the cloud.

Immunotherapy and PBT

2020年07月24日

The combination of proton therapy with immunotherapy is considered promising and has gained substantial interest over the last 2 years. According to Prof Justin Stebbing, an internationally acclaimed expert in immunotherapies for cancer, “the synergies between immunotherapy and radiotherapy can potentially allow for better treatment of cancers, improving both quality and quantity of life.” A recent paper published in the British Journal of Radiology shows that proton therapy might be better adapted to for combination with immunotherapy because it causes less damage to the immune cells and induces a stronger immune response due to a different cell death mechanism.

Ahead of the ASTRO conference in October

2020年06月25日

FLASH continues to prove its unique advantages in healthy tissue sparing with tumour control even in radioresistant cases. The LIGHT system is uniquely suited to application of FLASH at all depths. Currently we are investigating the delivery FLASH dose rates for a wide range of spot sizes. Follow us at upcoming ASTRO for more details!

New paths to proton therapy

2020年04月30日

On page 83-85 of Healthcare in London magazine, CEO of Advanced Oncotherapy plc, Nicolas Serandour provides an update on the development of the LIGHT system.

Nicolas Serandour's interview with London Suisse Luxe Magazine

2020年03月09日

Nicolas Serandour is CEO of Advanced Oncotherapy plc, a company not only at the forefront of developing a new proton beam therapy system, but also at the heart of a move to make this treatment available to people who would never normally have access to it.

Prognosis magazine interviewed Michael Sinclair, executive chairman of Advanced Oncotherapy

2020年02月27日

On bringing proton beam therapy, a revolutionary new cancer treatment, to Harley Street

A Win for Protons in Pediatric Brain Tumors

2019年12月23日

New data supporting the benefit of proton therapy is continuously emerging. See what Medpage says about proton therapy for paediatric brain tumours.

Advanced Oncotherapy readies first linear proton beam accelerator system for debut

2019年12月09日

Advanced Oncotherapy plc is starting verification and validation of the world’s first linear proton beam accelerator system, which is assembled and ready for testing at the Daresbury particle physics laboratory in Cheshire, U.K.

Advanced Oncotherapy PLC: Q&A with The Howard de Walden Estate

2019年09月23日

Building work at 141-143 Harley Street, the site of Advanced Oncotherapy’s first proposed commercial installation of LIGHT, has been recently completed. The Company just announced handover ahead of the fit-out process. Below is a Q&A with Simon Baynham, the property director at The Howard de Walden Estate, the landlord and developer of the Harley Street Medical Area.

PBT will become as common as MRI scanning

2019年08月09日

Because our LIGHT system has been designed to significantly reduce the treatment cost of patient and it can be installed in small to mid-size health care centres throughout the country, every patient ought to benefit from a proton therapy centre in their vicinity which is expected to drive patients’ demand for this treatment.

Advanced Oncotherapy: Democratising proton beam therapy

2019年07月08日

Check out the interview granted by Moataz Karmalawy, President of US division and Chief Commercial Officer of Advanced Oncotherapy.

FT: UK biotechs seek to speed up cancer detection

2019年06月07日

Nicolas Serandour speaks to Sarah Neville about how LIGHT's streamlined design is going to help to bridge the gap between resources and demand, and “democratise” proton beam therapy, a treatment that can make a difference.

The Times: Proton beams ‘better at treating brain tumours’.

2019年06月02日

The news could scarcely have been better for Harry Muldowney, a 10-year-old Herefordshire schoolboy with a brain tumour. Last month he became one of the first NHS patients to begin a potentially life-saving course of proton beam therapy, a pioneering cancer treatment.

Accelerating Innovation through International Collaboration

2019年03月22日

Prof Steve Myers, Executive Chair ADAM and former Director of Accelerators at CERN, was in Liverpool to talk about ‘Accelerating Innovation through International Collaboration’.

Girl, 9, survives inoperable cancer after proton beam therapy

2019年03月20日

The front page of the Times features the story of how Caroline, a 9-year-old British girl diagnosed with a rare inoperable cancer known as a rhabdomyosarcoma, has made a full recovery thanks to proton beam therapy. Also available on StoryTrender

A Meyrin, on dessine la firme de demain

2019年02月09日

[Article in French] Listed on the London Stock Exchange, Advanced Oncotherapy believes it has discovered a real vein: the development of a new system focused on proton therapy. This promising technology fights cancer.

AVO's linear proton accelerator LIGHT showcased on Japanese TV

2018年11月23日

In October 2018, NHK World TV visited the ADAM bunker facility in Geneva and interviewed ADAM Chairman, Former CERN Director of Accelerators and Technology, Prof. Stephen Myers OBE.

Effect of radiation exposure in brain tumours on hormone deficiencies

2018年08月21日

This article in the Journal of Clinical Oncology provides strong support for the benefits of advanced radiation technologies such as proton therapy for the treatment of brain tumours, especially in younger patients.

AVO’s CEO Nicolas Serandour: Proton therapy is going to become a reality for every cancer patient

2018年08月08日

AVO’s CEO Nicolas Serandour explains how the LIGHT system will significantly decrease the costs of proton therapy and allow to treat more kinds of cancer. “Proton therapy is going to become a reality for every cancer patient” - says Serandour

Proton therapy goes slimline-Manufacturers are reducing the size of proton-therapy systems to better compete with traditional radiotherapy

2018年08月01日

Physics World reports - Physics World reports on advances in proton therapy technology. Our LIGHT system is also discussed.

LIGHT was discussed at the first International Symposium on the Next Generation of Hadron Therapy in Tsukuba, Japan

2018年07月09日

CERN Courier - "The first model of LIGHT, a linac-based hadron-therapy system that operates at [200 Hz] with an energy sweep, and which is going to be installed at Harley Street, London" was discussed at the first International Symposium on the Next Generation of Hadron Therapy in Tsukuba, Japan. See the article in the last edition of the CERN Courier.

Beams of Life | Mega | in conversation with Stephen Myers

2018年05月23日

Proton therapy is a new way of beating cancer, with fewer side effects than conventional radiation treatments, explains Stephen Myers a pioneering nuclear medicine scientist.

All About Proton Therapy

2018年02月01日

Carolyn Vachani (University of Pennsylvania) - OncoLink.com - This article compares various radiation oncology techniques.

Therapeutic particles

2018年01月01日

Virginia Greco (CERN) - CERN Courier - The history of proton therapy.

Huge leap in prostate cancer testing

2018年01月01日

BBC news

Advanced Oncotherapy gets boost from stalwart investor

2017年12月10日

by Financial Times, Kate Burgess

AVO is fortunate to have investor stalwarts at its back

2017年12月10日

Financial Times - Investors trust, that the LIGHT system is the future of proton therapy.

Three ways to make proton therapy affordable

2017年09月01日

Thomas Bortfeld & Jay Loeffler (Mass. Gen. Hospital, Harvard Medical School) - Nature - Shrinking the accelerators and treatment room machines as well as model-based reimbursement decisions and pan-national referrals should decrease the cost of proton therapy and the scope of cancers treated.

Impact of spot charge inaccuracies in IMPT treatments

2017年08月01日

A.C. Kraan, N. Depauw, B. Clasie, M. Giunta, T. Madden, Hanne M. Kooy - Medical Physics Volume 44, Issue 8 - Pencil-beam scanning in proton therapy is even more accurate than what would be medically necessary.

Fundamental Research as a Driver for Disruption, Presentation by Prof Steve Myers

2017年06月23日

At its annual corporate event organised in Sardinia in 2017, Goetzpartners brought together personalities from all backgrounds. Prof Steve Myers, Executive Chairman of ADAM and Director of Advanced Oncotherapy plc, was invited to present the LIGHT Technology.

Director Talks meets Hans Van Celsing

2017年04月10日

Following his appointment at Senior Independent Non-Executive Director, Hans von Celsing talks to DirectorsTalk about his past experience, the present and his thoughts on the future of the company.

LIGHT: A Linear Accelerator For Proton Therapy

2016年10月01日

A. Degiovanni, P. Stabile, D. Ungaro (A.D.A.M. SA) - NAPAC2016, Chicago, IL, USA - A detailed presentation of our proton therapy system.

A(relatively) risky business: the link between prostatic radiotherapy and second malignancies

2016年03月01日

The BMJ - Radiotherapy increases the probability of secondary malignancies in prostate cancer patients. Another argument for a more wide-spread use of proton therapy?

Ashya King proton beam cancer therapy 'causes fewer side effects'

2016年01月01日

BBC News - Patient story about, how proton therapy is the better option in children's cancer.

Scientists put final pieces into place for seeing cancer with protons'

2016年01月01日

Proton beam are not only useful in radiation therapy, but also as an imagining technique.

Ashya King goes back to school full time'

2016年01月01日

The Guardian - Thanks to proton therapy treatment the little Ashya King recovered very fast.

Proton radiation therapy shows ongoing advancements throughout past quarter century'

2015年07月01日

TMC news - A timeline of proton beam therapy development.

The Physics of Proton Therapy

2015年03月01日

Wayne Newhauser & Rui Zhang - Physics in Medicine & Biology - Proton beam therapy explained by physicists.